Action Therapeutics
Semiconductor ManufacturingCalifornia, United States2-10 Employees
Pelvic pain las vegas Henderson incontinence pregnancy post partum tisdale McGinn Action therapeutics.
Growing Public Presence Action Therapeutics recently went public with an IPO, increasing its visibility and market credibility, which creates opportunities for partnerships, investor relations, and expanded industry engagement.
Niche Market Focus Specializing in pelvic pain, incontinence, pregnancy, and postpartum health, the company operates in a specialized healthcare segment with potential for targeted medical device or therapeutic collaborations.
Emerging Revenue Stream With revenue under 1 million dollars, there is significant growth potential, making the company an attractive prospect for technology upgrades, clinical partnerships, or distribution agreements to accelerate revenue.
Small but Nimble Team With a team of up to 50 employees, Action Therapeutics can quickly adapt and implement new solutions, facilitating pilot programs or early adoption of innovative technology in healthcare settings.
Tech Stack Readiness The company's use of modern web technologies indicates openness to digital engagement and remote service offerings, paving the way for telehealth integrations, digital marketing, or patient management solutions.
Action Therapeutics uses 8 technology products and services including Open Graph, oEmbed, GSAP, and more. Explore Action Therapeutics's tech stack below.
| Action Therapeutics Email Formats | Percentage |
| First@actiontherapeuticspt.com | 50% |
| First@actiontherapeuticspt.com | 50% |
Semiconductor ManufacturingCalifornia, United States2-10 Employees
Pelvic pain las vegas Henderson incontinence pregnancy post partum tisdale McGinn Action therapeutics.
Action Therapeutics's revenue is estimated to be in the range of $1M$10M
Action Therapeutics's revenue is estimated to be in the range of $1M$10M